Australia markets close in 6 hours 11 minutes

Therapeutic Solutions International, Inc. (TSOI)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0008+0.0002 (+33.33%)
At close: 03:48PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.54M
Enterprise value 3.40M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)19.21
Price/book (mrq)2.26
Enterprise value/revenue 34.33
Enterprise value/EBITDA -2.28

Trading information

Stock price history

Beta (5Y monthly) 1.33
52-week change 3-71.29%
S&P500 52-week change 322.38%
52-week high 30.0033
52-week low 30.0004
50-day moving average 30.0008
200-day moving average 30.0012

Share statistics

Avg vol (3-month) 323.33M
Avg vol (10-day) 341.99M
Shares outstanding 54.23B
Implied shares outstanding 64.23B
Float 83.26B
% held by insiders 119.06%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,336.14%

Management effectiveness

Return on assets (ttm)-36.00%
Return on equity (ttm)-166.83%

Income statement

Revenue (ttm)98.99k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)177.80%
Gross profit (ttm)N/A
EBITDA -1.67M
Net income avi to common (ttm)-2.17M
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)27.82k
Total cash per share (mrq)0
Total debt (mrq)888.06k
Total debt/equity (mrq)69.28%
Current ratio (mrq)0.05
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-1.06M
Levered free cash flow (ttm)-218.15k